Genetron Health to Announce First Quarter 2021 Financial Results and Host Investor Call on May 24, 2021

Genetron Holdings Limited, a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that it will report unaudited financial results for the first quarter ended March 31, 2021 on May 24, 2021 before the US market open.

Management will host a conference call for investors at 8:30 a.m. ET (8:30 p.m. Beijing time) on Monday, May 24, 2021. The conference call can be accessed by dialing the following numbers:

United States: +1-845-675-0437
China Domestic: 400-620-8038
Hong Kong: +852-3018-6771
International: +65-6713-5090
Conference ID: 7689525

Participants are encouraged to dial into the call at least 15 minutes in advance due to high call volumes.

A replay will be accessible through May 31, 2021 by dialing the following numbers:

Telco replay number

United States: +1-855-452-5696
International: +61-2-8199-0299
Conference ID: 7689525

A simultaneous webcast of the conference call will be available on the “News and Events” page of the Investors section of the Company’s website. A replay of the webcast will be available for 30 days following the event.

About Genetron Holdings Limited

Genetron Holdings Limited is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment.

The Company has developed a comprehensive oncology portfolio that covers the entire spectrum of cancer management, addressing needs and challenges from early screening, diagnosis and treatment recommendations, as well as continuous disease monitoring and care.

Genetron Health also partners with global biopharmaceutical companies and offers customized services and products.

For more information, please visit